0000919574-15-005180.txt : 20150702 0000919574-15-005180.hdr.sgml : 20150702 20150702131750 ACCESSION NUMBER: 0000919574-15-005180 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150702 DATE AS OF CHANGE: 20150702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kovner Bruce CENTRAL INDEX KEY: 0001325713 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 15968433 MAIL ADDRESS: STREET 1: C/O CAXTON ASSOCIATES STREET 2: 500 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 p6680514.xml BRUCE/SYNTA X0306 4 2015-06-30 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001325713 Kovner Bruce C/O CAXTON CORPORATION 731 ALEXANDER ROAD, BLDG. 2 PRINCETON NJ 08540 1 0 1 0 Common Stock 2015-06-30 4 J 0 2279146 A 2279146 I By wife Common Stock 2015-06-30 4 J 0 250000 D 0 I By Kovner 2011 Family Trust Common Stock 2015-06-30 4 J 0 125000 D 0 I By Kovner 2011-C Investment Trust Common Stock 2015-06-30 4 J 0 125000 D 0 I By Kovner 2011-D Investment Trust Common Stock 2015-06-30 4 J 0 475000 D 0 I By Kovner 2012 Family Trust A Common Stock 2015-06-30 4 J 0 475000 D 0 I By Kovner 2012-B Synta Investment Trust Common Stock 2015-06-30 4 J 0 475000 D 0 I By Kovner 2012-C Synta Investment Trust Common Stock 2015-06-30 4 J 0 354146 D 120854 I By Kovner 2012-D Synta Investment Trust Common Stock 2015-07-01 4 A 0 22727 A 3083587 D Common Stock 2015-07-01 4 A 0 4545 A 3088132 D Common Stock 2015-07-01 4 A 0 4545 A 3092677 D Common Stock 15278610 I By KFO Holdings LLC Common Stock 5460000 I By OB Select Opportunities, LLC Common Stock 7761716 I By CxSynta LLC Common Stock 3100000 I By Kovner 2012 Family Trust B Director Stock Option (Right to Buy) 2.20 2015-07-01 4 A 0 20000 0 A 2025-07-01 Common Stock 20000 20000 D Reflects the transfer of a total of 2,279,146 shares from the Kovner 2011 Family Trust, Kovner 2011-C Investment Trust, Kovner 2011-D Investment Trust, Kovner 2012 Family Trust A, Kovner 2012-B Synta Investment Trust, Kovner 2012-C Synta Investment Trust, and Kovner 2012-D Synta Investment Trust to the wife of the Reporting Person. These securities are owned by the wife of the Reporting Person. These shares are owned directly by KFO Holdings LLC ("KFO") and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of KFO. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. These shares are owned directly by OB Select Opportunities, LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of OB Select Opportunities, LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date. Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a member of the Compensation Committee of the Board of Directors of the Issuer on such date. Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a member of the Nominating and Governance Committee of the Board of Directors of the Issuer on such date. The option vests as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date. /s/ Heath N. Weisberg, Attorney-In-Fact 2015-07-02